361 related articles for article (PubMed ID: 10931555)
1. Engineered protein scaffolds for molecular recognition.
Skerra A
J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
[TBL] [Abstract][Full Text] [Related]
2. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
3. Alternative non-antibody scaffolds for molecular recognition.
Skerra A
Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
[TBL] [Abstract][Full Text] [Related]
4. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
6. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
Skerra A
FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
[TBL] [Abstract][Full Text] [Related]
7. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
8. The fibronectin type III domain as a scaffold for novel binding proteins.
Koide A; Bailey CW; Huang X; Koide S
J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
[TBL] [Abstract][Full Text] [Related]
9. Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold.
Juraja SM; Mulhern TD; Hudson PJ; Hattarki MK; Carmichael JA; Nuttall SD
Protein Eng Des Sel; 2006 May; 19(5):231-44. PubMed ID: 16549402
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding.
Hoyer W; Härd T
J Mol Biol; 2008 Apr; 378(2):398-411. PubMed ID: 18358490
[TBL] [Abstract][Full Text] [Related]
11. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
12. Binding proteins from alternative scaffolds.
Nygren PA; Skerra A
J Immunol Methods; 2004 Jul; 290(1-2):3-28. PubMed ID: 15261569
[TBL] [Abstract][Full Text] [Related]
13. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
Schlehuber S; Skerra A
Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
[TBL] [Abstract][Full Text] [Related]
14. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two.
Parker MH; Chen Y; Danehy F; Dufu K; Ekstrom J; Getmanova E; Gokemeijer J; Xu L; Lipovsek D
Protein Eng Des Sel; 2005 Sep; 18(9):435-44. PubMed ID: 16087651
[TBL] [Abstract][Full Text] [Related]
15. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
Vogt M; Skerra A
Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
[TBL] [Abstract][Full Text] [Related]
16. Engineering of a femtomolar affinity binding protein to human serum albumin.
Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional studies of titin's fn3 modules reveal conserved surface patterns and binding to myosin S1--a possible role in the Frank-Starling mechanism of the heart.
Muhle-Goll C; Habeck M; Cazorla O; Nilges M; Labeit S; Granzier H
J Mol Biol; 2001 Oct; 313(2):431-47. PubMed ID: 11800567
[TBL] [Abstract][Full Text] [Related]
18. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
19. Engineering novel binding proteins from nonimmunoglobulin domains.
Binz HK; Amstutz P; Plückthun A
Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
[TBL] [Abstract][Full Text] [Related]
20. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
Nygren PA
FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
